Publicaciones en colaboración con investigadores/as de University of Glasgow (30)

2023

  1. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors

    Biological psychiatry, Vol. 91, Núm. 3, pp. 313-327

2021

  1. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. Response to Letter to the Editor: Palm Oil and Beta-Palmitate in Infant Formula

    Journal of Pediatric Gastroenterology and Nutrition

2019

  1. Comparative genomics of the major parasitic worms

    Nature Genetics, Vol. 51, Núm. 1, pp. 163-174

  2. Feeding the Late and Moderately Preterm Infant: A Position Paper of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition

    Journal of Pediatric Gastroenterology and Nutrition, Vol. 69, Núm. 2, pp. 259-270

  3. Palm oil and beta-palmitate in infant formula: A position paper by the european society for paediatric gastroenterology, hepatology, and nutrition (espghan) committee on nutrition

    Journal of Pediatric Gastroenterology and Nutrition, Vol. 68, Núm. 5, pp. 742-760

2018

  1. Quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 1: Individual participant data meta-analysis and health economic analysis

    BMJ Open, Vol. 8, Núm. 4

  2. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies

    The Lancet, Vol. 391, Núm. 10129, pp. 1513-1523

  3. Study protocol: Quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 2, UK Prospective Cohort Study

    BMJ Open, Vol. 8, Núm. 4

2017

  1. An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis

    Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457

2016

  1. Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: A meta-analysis

    JAMA - Journal of the American Medical Association, Vol. 316, Núm. 13, pp. 1383-1391

2015

  1. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35

  2. Journal Club via social media: Authors take note of the impact of #BlueJC

    BJOG: An International Journal of Obstetrics and Gynaecology

  3. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension

    Circulation Research, Vol. 117, Núm. 10, pp. 870-883

  4. Specific Cell Targeting Therapy Bypasses Drug Resistance Mechanisms in African Trypanosomiasis

    PLoS Pathogens, Vol. 11, Núm. 6

2014

  1. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

    Arthritis Research and Therapy, Vol. 16, Núm. 1

2013

  1. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

    New England Journal of Medicine, Vol. 369, Núm. 26, pp. 2492-2503

  2. Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 602-607

  3. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 7, pp. 1233-1238